We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIPO.WS
3226
CALL
DELISTED
Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share
HIPO.WS
$44K ﹤0.01%
23,006
-18,371
-44% -$6.37K
GRTX
3227
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$43K ﹤0.01%
18,004
-378
-2% -$985
DDL
3228
Dingdong
DDL
$527M
$42K ﹤0.01%
+11,813
New +$72.4K
AACG
3229
ATA Creativity
AACG
$41.9M
$40K ﹤0.01%
+26,229
New +$40.9K
CTMX icon
3230
CytomX Therapeutics
CTMX
$701M
$40K ﹤0.01%
+15,266
New +$58.6K
TOON icon
3231
Kartoon Studios
TOON
$34.8M
$38K ﹤0.01%
3,695
FSTX
3232
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$37K ﹤0.01%
+10,456
New +$38.6K
SOGP
3233
Sound Group
SOGP
$51.3M
$31K ﹤0.01%
2,090
+781
+60% +$11.6K
FLNT
3234
Fluent
FLNT
$103M
$28K ﹤0.01%
+2,238
New +$22.8K
CABA icon
3235
Cabaletta Bio
CABA
$445M
$26K ﹤0.01%
12,718
+5,774
+83% +$15.1K
REAX icon
3236
Real Brokerage
REAX
$375M
$25K ﹤0.01%
11,056
-8,512
-43% -$21.9K
SEAC
3237
DELISTED
Seachange International Inc
SEAC
$24K ﹤0.01%
+1,026
New +$26K
XFOR icon
3238
X4 Pharmaceuticals
XFOR
$371M
$23K ﹤0.01%
437
-1,579
-78% -$90.6K
MTL
3239
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$22K ﹤0.01%
45,477
-56,694
-55% -$180K
ASXC
3240
DELISTED
Asensus Surgical, Inc.
ASXC
$21K ﹤0.01%
+32,700
New +$25.2K
QNGY
3241
DELISTED
Quanergy Systems, Inc.
QNGY
$21K ﹤0.01%
598
-73,119
-99% -$8.18M
MU icon
3242
PUT
Micron Technology
MU
$927B
$16K ﹤0.01%
200
-804,600
-100% -$68.6M
BEST
3243
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$13K ﹤0.01%
+958
New +$15.1K
X
3244
CALL
DELISTED
US Steel
X
$8K ﹤0.01%
200
-636,700
-100% -$17.2M
AA icon
3245
Alcoa
AA
$11.7B
-36,497
Closed -$2.17M
AAOI icon
3246
Applied Optoelectronics
AAOI
$7.07B
-69,543
Closed -$357K
ABCB icon
3247
Ameris Bancorp
ABCB
$5.9B
-29,354
Closed -$1.46M
ACIU icon
3248
AC Immune
ACIU
$236M
-8,855
Closed -$44K
ACR
3249
ACRES Commercial Realty
ACR
$129M
-6,812
Closed -$85K
ACRE
3250
Ares Commercial Real Estate
ACRE
$256M
-1,080
Closed -$16K

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.